Resting Energy Expenditure and Substrate Consumption in Cardiac Arrest Patients Under Target Temperature Management
NCT ID: NCT06575101
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40 participants
OBSERVATIONAL
2024-06-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Target Temperature Management on Intestinal Flora and Its Metabolites in Patients With Cardiac Arrest
NCT06974682
Research on Key Technologies and System Optimization of Early Warning and Resuscitation of Cardiac Arrest
NCT04955288
Prognostic Indicators of Survival Following Cardiopulmonary Resuscitation in Patients With Cardiac Arrest
NCT03597425
To Compare Predictive Power of End-tidal Carbon Dioxide Between Different Time Line During Resuscitation
NCT03345888
Predictive Value of Sublingual Microcirculation and Peripheral Tissue Oxygen Monitoring
NCT03859726
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
33℃ group
Target Temperature Management Treatment
Target Temperature Management Treatment
36℃ group
Target Temperature Management Treatment
Target Temperature Management Treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Target Temperature Management Treatment
Target Temperature Management Treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Successfully resuscitated, and are unconscious after restoration of spontaneous circulation (ROSC);
* Be admitted to the intensive care unit (ICU) for advanced life support such as endotracheal intubation after restoration of spontaneous circulation (ROSC);
* Accepted target temperature management (TTM) therapy after restoration of spontaneous circulation (ROSC);
Exclusion Criteria
* Incomplete clinical data and loss of follow-up;
* Traumatic brain injury or cerebrovascular accident revealed by computed tomography (CT);
* Severe metabolic abnormalities are known: cachexia, thyroid dysfunction, and cancer;
* Indirect calorimetry measurement is not possible such as sustained oxygen concentration \> 70%;
* There were no signs of resuscitation at the time of admission;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tang Ziren
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tang Ziren
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing chao-yang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-4-15-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.